NOT KNOWN FACTUAL STATEMENTS ABOUT BLOCK PAIN RECEPTORS WITH PROLEVIATE

Having identified the palmitoylation motif of APLNR, we created a brief substrate sequence to competitively inhibit the palmitoylation of endogenous APLNR. This competitive peptide, which targets the APLNR palmitoylation web-site together with morphine, can inhibit the event of NCP, together with pain incidence, microglial activation, and inflammat